VERAXA Biotech AG (NASDAQ: VRXA) Strengthens Scientific Leadership as New CSO Takes the Helm in Advancing BiTAC(R) Cancer Therapy Platform

9 hours ago
Lacey@GCS

The company has appointed antibody therapeutics specialist Dr. Christoph Erkel as Chief Scientific Officer. The leadership change comes as the…

OpenAI Admits its AI Models Went Rogue, Hacked Hugging Face

1 day ago

OpenAI has announced that it is investigating what it describes as an unusual cyber incident involving a pair of its…

VC Funding for Crypto Keeps Flowing While DeFi Funding Dwindles

5 days ago

Venture capital funding continues to support the cryptocurrency industry even as investment in decentralized finance (DeFi) keeps falling. New data…

Quantum Supercomputers Identify Possible Source of Nuclear Fusion Fuel

6 days ago

Scientists have reached an exciting milestone in the search for clean energy by using quantum-centric supercomputers to study a possible…

VERAXA Biotech AG (NASDAQ: VRXA) Advances BiTAC(R)-TCE Development with Positive Regulatory Feedback from Germany

1 week ago

The company has received Scientific Advice from Germany’s Paul-Ehrlich-Institute (“PEI”) supporting the proposed development strategy for its lead BiTAC(R)-TCE program.…

Guterres Calls for Humanity’s Involvement in Shaping AI Trajectory

1 week ago

Artificial intelligence (AI) is changing the world faster than ever before. It is helping people improve healthcare, education, farming, business,…

EV Battery Health Checks Could Soon Become Routine Under New Partnership

2 weeks ago

Electric vehicles are becoming more common on roads across the UK, and many people are choosing them because they produce…

Regional Conflict Puts Dubai Crypto Hub to the Test

2 weeks ago

Dubai has become one of the world's leading centers for cryptocurrency and blockchain businesses. Its business-friendly environment, clear regulations, and…

Ford Provides a Peek at its New Electric Pickup Truck

2 weeks ago

Ford has shared new details about its future electric pickup truck, giving people a better idea of what to expect.…

Why VERAXA Biotech AG (NASDAQ: VRXA) Could Benefit More Than Others From AI’s Growing Impact on Drug R&D 

2 weeks ago

Artificial intelligence is becoming an increasingly important tool for drug discovery, with major pharmaceutical companies expanding AI collaborations across oncology…